Use of Neuronal-Enriched Extracellular Vesicles to Distinguish Cognitive Impairment Levels and Sex Differences in People with HIV
Authors:
- Norina TangNTNorina Tang
- Fan XiaFXFan Xia
- Heather FreasierHFHeather Freasier
- Phyllis C. TienPTPhyllis C. Tien
- Marshall J. GlesbyMGMarshall J. Glesby
- Daniel MerensteinDMDaniel Merenstein
- Audrey L. FrenchAFAudrey L. French
- Heather McKayHMHeather McKay
- Monica M. DiazMDMonica M. Diaz
- Igho OfotokunIOIgho Ofotokun
- Jordan E. LakeJLJordan E. Lake
- Joseph B. MargolickJMJoseph B. Margolick
Open Access
Abstract
Cognitive impairment still occurs despite well-controlled HIV but with milder symptoms. People with and without HIV have different neuronal protein changes that may differentiate the asymptomatic neurocognitive impairment (ANI) condition from normal cognition (NPN) and mild neurocognitive disorder (MND). Plasma neuronal-enriched extracellular vesicles (nEVs) were isolated from people with HIV (PWH) with NPN, ANI, or MND, and HIV seronegative controls with NPN (HIV−). Two different platforms were used to delineate protein patterns between sexes and cognitive conditions. When combining results from men and women, the nEV cargo in many cases showed little difference between cognitive conditions. However, when separated, there were different patterns between the sexes for some nEV cargo that distinguished the HIV− groups and HIV+ cognition groups. PWH with NPN had higher nEV toxic proteins compared to individuals without HIV. Women with HIV showed perfect separation between NPN and ANI with Aβ42 and NCAM-1 and perfect separation between ANI and MND with Aβ40 and NCAM-1. Men with HIV with MND had significantly higher NCAM-1 when compared to ANI, and lower GLRX when compared to NPN. This study shows distinct markers for different HIV cognitive categories, many of which differed between men and women.Keywords
Funding Information
- National Institute of Mental Health (R01MH121121)
- UCSF-Bay Area Center for AIDS Research (P30AI027763)
This publication has 61 references indexed in Scilit:
- Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer DiseaseJAMA Neurology, 2025
- The Reproductive Transition: Effects on Viral Replication, Immune Activation, and Metabolism in Women with HIV infectionCurrent HIV/AIDS Reports, 2021
- Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegenerationJournal of Neural Transmission, 2021
- Trends in Age at Natural Menopause and Reproductive Life Span Among US Women, 1959-2018JAMA, 2021
- Association between serum NPTX2 and cognitive function in patients with vascular dementiaBrain and Behavior, 2020
- Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIVJournal of NeuroVirology, 2020
- White matter damage, neuroinflammation, and neuronal integrity in HANDJournal of NeuroVirology, 2018
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control studyAlzheimer's & Dementia, 2014
- Structural insights into Alzheimer filament assembly pathways based on site‐directed mutagenesis and S‐glutathionylation of three‐repeat neuronal Tau proteinMicroscopy Research and Technique, 2005
- Modulation of the redox state of tubulin by the glutathione/glutaredoxin reductase systemBiochemical and Biophysical Research Communications, 2004